| Patents for C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939) |
|---|
| 04/11/2002 | US20020042508 Highly enantiomerically pure lactam-substituted propanoic acid derivatives and methods of making and using same |
| 04/11/2002 | US20020042442 Ureas and carbamates of N-Heterocyclic carboxylic acids and carboxylic acid isosteres |
| 04/11/2002 | US20020042431 Zwitterionic tachykinin receptor antagonists |
| 04/11/2002 | US20020042430 Novel esters of 1, 4-disubstituted piperidine derivatives |
| 04/11/2002 | US20020042413 Central nervous system disorders; cognition activators |
| 04/11/2002 | US20020042396 Amino acid derivatives |
| 04/11/2002 | US20020042357 Polypharmacophoric agents |
| 04/11/2002 | CA2424684A1 Nitroso diphenylamine derivatives |
| 04/11/2002 | CA2424190A1 Process for the synthesis of 2,2,6,6-tetramethyl-4-oxopiperidine |
| 04/11/2002 | CA2419777A1 Pharmaceutical compounds |
| 04/10/2002 | EP1194150A1 Use of nitroxides in wound healing and in the prevention of photodamage |
| 04/10/2002 | EP1087662B1 Composition for keeping away vermin |
| 04/10/2002 | EP1015447B1 Piperidinylmethyloxazolidinone derivative |
| 04/10/2002 | EP0882124B1 Cleaning process and composition |
| 04/10/2002 | CN1344266A Novel compounds |
| 04/10/2002 | CN1343663A Amlodipine-series salts and preparing process and application thereof |
| 04/10/2002 | CN1082519C Stablizer compsn. and stablizing method of natural or synthetic polymer or pre-polymerizing substrate |
| 04/10/2002 | CN1082371C NK-1 receptor antagonist and 5HT3 receptor antagonists for treating emesis |
| 04/09/2002 | US6369194 Alpha-beta-diketo compounds produced by reacting an alpha-keto acid or acid chloride with a ylide such as (cyanomethylene)phosphoranes, oxidizing the cyano diketo phoshorane and reacting with a nucleophile |
| 04/09/2002 | US6368520 Synergistic stabilizer mixture |
| 04/04/2002 | WO2002026750A2 Phosphino-aminophosphines, catalyst complexes and enantioselective hydrogenation |
| 04/04/2002 | WO2002026711A1 Pharmaceutically active benzsulfonamide derivatives as inhibitors of protein junkinases |
| 04/04/2002 | WO2002026709A1 Process for producing multiform crystal of donepezil hydrochloride |
| 04/04/2002 | WO2002026705A2 Highly enantiomerically pure lactam-substituted propanoic acid derivatives and their preparation |
| 04/04/2002 | WO2001098266A3 N-and o-substituted 4-[2-(diphenylmethoxy)-ethyl]-1-[(phenyl)methyl]piperidine analogs and methods of treating cns disorders therewith |
| 04/04/2002 | WO2001094313A3 Crystal modification of fexofenadine |
| 04/04/2002 | WO2001094301A3 Factor viia inhibitory (thio)urea derivatives, their preparation and their use |
| 04/04/2002 | WO2001085694A3 Substituted diamide derivatives useful as motilin antagonists |
| 04/04/2002 | WO2001081308A3 Aminopiperidines for use as glyt-1 inhibitors |
| 04/04/2002 | US20020040162 Contrast media for angiography |
| 04/04/2002 | US20020040145 Used for stabilizing polyolefin and automotive coating formulation against the deleterious effects of oxidative, thermal and actinic radiation |
| 04/04/2002 | US20020040038 Administering donepezil or its hydrochloride salt |
| 04/04/2002 | US20020040037 Prodrug acid esters of [2-(4-benzyl-3-hydroxy-piperidin-1-yl)-ethansulfonyl]phenol |
| 04/04/2002 | US20020040036 1-(4-bromophenyl)-2-(1-methyl-2-piperidinyl)-1-ethanone, for example; treating neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease, Korsakoff's disease and frontal lobe and subcortical dementias |
| 04/04/2002 | US20020040024 A phenoxy substituted piperidine derivative, useful for treating or preventing histamine H3 receptor activity |
| 04/04/2002 | DE10044792A1 Substituierte Phenylcyclohexancarbonsäureamide und ihre Verwendung Substituted Phenylcyclohexancarbonsäureamide and their use |
| 04/03/2002 | EP1193256A1 Pharmaceutically active benzsulfonamide derivatives as inhibitors of JNK proteins |
| 04/03/2002 | EP1193255A1 Heterocyclic compounds and medicinal use thereof |
| 04/03/2002 | EP1192137A1 COMPOUNDS FOR THE MODULATION OF PPAR$g(g) ACTIVITY |
| 04/03/2002 | EP1192136A2 Oligomers and polymers of cyclic imino carboxylic acids |
| 04/03/2002 | EP1192135A2 Serine protease inhibitors |
| 04/03/2002 | EP1192134A2 Processes for the preparation of (r)-g(a)-(2,3-dimethoxyphenyl)-1-(2-(4-fluorophenyl)ethyl)-4-piperidinemethanol |
| 04/03/2002 | EP1192133A1 N-cyclopentyl modulators of chemokine receptor activity |
| 04/03/2002 | EP1192132A2 Serine protease inhibitors |
| 04/03/2002 | EP1192128A1 Thiol derivative, metallo-beta-lactamase inhibitors |
| 04/03/2002 | EP1191932A1 Production of agglomerates of inogatran and the compound inogatran anhydrate |
| 04/03/2002 | EP1161240A4 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
| 04/03/2002 | EP1158980A4 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
| 04/03/2002 | EP1156807A4 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
| 04/03/2002 | EP1140087A4 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
| 04/03/2002 | CN1082066C Synergistic stabilizer mixture |
| 04/02/2002 | US6365604 For therapy of psychotic disorders |
| 04/02/2002 | US6365602 For therapy of depression, anxiety, asthma, pain, inflammation, urinary incontinence and other disease conditions |
| 04/02/2002 | US6365587 Substituted aryl hydroxamic acids as metalloproteinase inhibitors |
| 04/02/2002 | US6365125 Using organotin compound |
| 04/02/2002 | CA2357925A1 Prophylactic use of n-methyl-d-asparate (nmda) antagonists |
| 04/02/2002 | CA2059610C 1,2,3,4-tetrahydrocyclopent[b]indoles, 1,2,3,3a,4,8a-hexahydrocyclopent[b]indoles and related compounds, intermediates and a process for the preparation thereof and their use as medicaments |
| 04/02/2002 | CA2039909C Substituted 3-thia- and 3-oxa-alkylflavones, a process for their preparation, the use thereof, medicaments based on these compounds and intermediates |
| 03/28/2002 | WO2002024649A1 Substituted amino-aza-cycloalkanes useful against malaria |
| 03/28/2002 | WO2002024636A2 N-acylsulfonamide apoptosis promoters |
| 03/28/2002 | WO2002024632A2 Substituted aminopropoxyaryl derivatives useful as agonists for lxr |
| 03/28/2002 | WO2002024629A1 Zwitterionic tachykinin receptor antagonists |
| 03/28/2002 | WO2001085169A3 R-eliprodil for treating glaucoma |
| 03/28/2002 | WO2001085152A3 R-eliprodil for treating glaucoma |
| 03/28/2002 | WO2001074762A3 Arylsulfates and their use as enhancers or inhibitors of bioadhesion to surfaces |
| 03/28/2002 | WO2001068604A3 3-substituted piperidines comprising urea functionality, and methods of use thereof |
| 03/28/2002 | WO2001064676A3 INHIBITORS OF p38-α KINASE |
| 03/28/2002 | US20020038031 For inhibiting the serotonin and/or noradrenaline reuptake, and are useful as medicaments in disorders in which an increase of levels of those neurotransmitters is necessary |
| 03/28/2002 | US20020038025 For therapy and prophylaxis of hypercholesterolemia, hyperlipemia, arteriosclerosis, vascular diseases, mycoses, parasite infections, gallstones, tumors and/or hyperproliferative disorders, diabetes |
| 03/28/2002 | US20020037931 Treating mood disorders, Parkinson's disease, disorders of the gastrointestinal system, edema formation states and hypertension; for example, 6,7-dihydroxy-8-nitro-3,4-dihydro-2H-naphthalen-1-one |
| 03/28/2002 | US20020037907 Substituted 2- (S) -hydroxy-3- (piperidin-4-yl-methylamino) -propyl ethers and substituted 2-aryl-2- (R) - hydroxy-1- (piperidin-4-yl-methyl) -ethylamine beta-3 adrenergic receptor agonists |
| 03/28/2002 | US20020037896 Bicyclic compounds |
| 03/28/2002 | US20020037895 Wherein the lactone ring is modified; preventing or treating disorders or diseases mediated by LFA-1 (Leukocyte Function-associated Antigen-1) ICAM-1 (intercellular adhesion molecules) interactions; autoimmune disorders, inflammation |
| 03/28/2002 | CA2423356A1 Zwitterionic tachykinin receptor antagonists |
| 03/28/2002 | CA2423315A1 Substituted amino-aza-cycloalkanes useful against malaria |
| 03/27/2002 | EP1191611A2 Piezoelectric element and process for production thereof |
| 03/27/2002 | EP1191022A1 Novel dihydropyridine derivative |
| 03/27/2002 | EP1191021A1 Dihydropyridine derivative |
| 03/27/2002 | EP1189929A2 Factor viia inhibitors |
| 03/27/2002 | EP1189886A1 Ethanesulfonyl-piperidine derivatives |
| 03/27/2002 | EP1189875A2 Mono and multifunctional alkoxyamines for the preparation of functionalized macromers |
| 03/27/2002 | EP1189612A1 Vla-4 inhibitor compounds |
| 03/27/2002 | EP0843661B1 (1s,2s)-1-(4-hydroxyphenyl)-2-(4-hydroxy-4-phenylpiperidin-1-yl)-1-propanolmethanesulfonate trihydrate |
| 03/27/2002 | CN1342074A Antidepressant heterocyclic compounds |
| 03/27/2002 | CN1341593A Proteinase inhibitor |
| 03/27/2002 | CN1341592A Proteinase inhibitor |
| 03/27/2002 | CN1341590A Proteinase inhibitor |
| 03/27/2002 | CN1081625C 1-aryl-2-acylamino-ethane compounds and their use as meurokinin especially neurokinin 1 antagonists |
| 03/26/2002 | US6362373 Chiral amino alcohols and process for preparation of same |
| 03/26/2002 | US6362371 β2- adrenergic receptor agonists |
| 03/26/2002 | US6362210 Carboxylic acid amides, pharmaceutical compositions containing these compounds and their use |
| 03/26/2002 | US6362203 4-hydroxy-4-phenylpiperidine derivatives and pharmaceuticals containing the same |
| 03/26/2002 | US6362200 Antitumor dibenzofluorene derivatives |
| 03/26/2002 | US6362183 Aromatic sulfonyl alpha-hydroxy hydroxamic acid compounds |
| 03/26/2002 | US6362009 Solid phase synthesis of heterocycles |
| 03/26/2002 | US6361987 Useful for preparing intermediates for the synthesis of optically active 1,4-dihydropyridine derivatives which are well known per se and useful as prophylactic and therapeutic agents for ischemic heart diseases, hypertension |
| 03/26/2002 | CA2063030C Substituted n-phenylpiperidines and drugs therefrom |
| 03/26/2002 | CA2032498C Novel 8-substituted-2-aminotetralines |
| 03/21/2002 | WO2002022592A2 Substituted urea neuropeptide y y5 receptor antagonists |
| 03/21/2002 | WO2002022582A2 Solid salt forms of n-[2-[4-[2-(1-methylethoxy)phenyl]-1-piperazinyl]ethyl]-2-oxo-1-piperidineacetamide |